Eikon

Eikon Therapeutics is an emerging biopharmaceutical company that employs revolutionary technologies in the fields of biology, engineering, and chemistry to discover new therapies for life-threatening diseases. Eikon's discovery platform is built on its founders' groundbreaking innovations, culminating in the creation of a microscope capable of measuring protein movements within living cells in real time and at molecular resolution. Eikon's signature assay method enables the highly sensitive identification of compound-protein interactions.